| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4460156
Max Phase: Preclinical
Molecular Formula: C17H26N4O3
Molecular Weight: 334.42
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1ccc(NC(=O)C(=O)NC2CC(C)(C)NC(C)(C)C2)cn1
Standard InChI: InChI=1S/C17H26N4O3/c1-16(2)8-12(9-17(3,4)21-16)20-15(23)14(22)19-11-6-7-13(24-5)18-10-11/h6-7,10,12,21H,8-9H2,1-5H3,(H,19,22)(H,20,23)
Standard InChI Key: VHRACZSNRXJUQI-UHFFFAOYSA-N
Associated Targets(non-human)
Envelope glycoprotein gp160 755 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 334.42 | Molecular Weight (Monoisotopic): 334.2005 | AlogP: 1.45 | #Rotatable Bonds: 3 |
| Polar Surface Area: 92.35 | Molecular Species: BASE | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.46 | CX Basic pKa: 10.34 | CX LogP: 0.62 | CX LogD: -1.95 |
| Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.73 | Np Likeness Score: -1.75 |
References
| 1. Kobayakawa T, Konno K, Ohashi N, Takahashi K, Masuda A, Yoshimura K, Harada S, Tamamura H.. (2019) Soluble-type small-molecule CD4 mimics as HIV entry inhibitors., 29 (5): [PMID:30665681] [10.1016/j.bmcl.2019.01.011] |
Source
Source(1):